Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer

Gail Darling(University Health Network), Marc de Perrot(University Health Network), Demetris Patsios(University Health Network), Shaf Keshavjee(University Health Network), Marcelo Cypel(University Health Network), Fei Li(University Health Network), Andrew Pierre(University Health Network), Linda Coate(University Health Network), Adam Wallis(University Health Network), Kazuhiro Yasufuku(University Health Network), Christine Massey(University of Vermont)
European Journal of Cardio-Thoracic Surgery
January 6, 2015
Cited by 44


Related Papers